Are compounded peptides FDA-approved?

No. Compounded medications can meet an individual patient's medical need, but they are not FDA-approved and are not reviewed like approved finished drugs. The FDA does not evaluate each compounded product for safety, effectiveness, or quality before it is dispensed.

Compounded is not the same as approved

An FDA-approved drug has been through controlled clinical trials, a defined manufacturing process, a reviewed safety profile, and approved prescribing information. A compounded medication is prepared by a licensed pharmacy for a specific patient and does not go through that review.

That distinction does not make compounding improper — it makes physician oversight and pharmacy accountability essential.

What protections still apply

Compounding through licensed U.S. pharmacies brings a prescriber-patient relationship, screening for medical risks and interactions, pharmacy labeling and dosing instructions, identifiable sourcing and handling standards, follow-up when side effects occur, and a route for reporting product-quality problems.

Those protections reduce some risks. They do not convert limited evidence into strong evidence.

Medically reviewed by Dr. Michael Mimlitz, MD (NPI 1508891870), Chief Physician of GOAL.MD. Physician-supervised telehealth. More at goal.md/answers.